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Diabetes is a demanding disease with amajor effect on the quality of life ofpatients and their families (1,2).
Research has suggested that psychological
distress frequently occurs in people with
diabetes and is often related to difficulties in
coping with the daily regimen and worries
about developing late complications (3,4).
Psychological distress is not only burden-
some itself, but also it can impede the self-
care behaviors of the patients, thereby
compromising glycemic control (5–7). To
quantify levels of emotional distress in peo-
ple with diabetes, various measures have
been developed in the U.K., Germany,
Canada, and U.S. (8–11). As Glasgow et al.
(12) recently showed, research must estab-
lish the relative strengths and weaknesses of
the various diabetes-specific instruments,
particularly their sensitivity to detect
changes and intervention effects (12). We
further emphasize the importance of cross-
cultural validation of such questionnaires.
Psychosocial research in diabetes could ben-
efit significantly from standardization of
instruments to allow for international com-
parison of results (13).
The Problem Areas in Diabetes Scale
(PAID) is a brief self-report measure of dia-
betes-related distress that has been found to
be valid and clinically useful in U.S. type 1
and type 2 diabetic patients (14–16). PAID
scores have been found to show positive
associations with HbA1c and are a major
predictor of poor adherence to treatment
not involving general emotional distress.
The PAID seems to be a good candidate for
the measurement of diabetes-related dis-
tress across countries, but its cross-cultural
validity has yet to be established. Ishii et al.
(17) found evidence to support the clinical
utility of a Japanese version of the PAID in
a sample of predominantly type 2 diabetic
patients. In this article, we report on the
validation of the Dutch version of the PAID
by comparing PAID scores across samples
of Dutch and U.S. diabetic patients.
RESEARCH DESIGN AND 
METHODS
Subjects
As part of a large survey (18), 3,000 ran-
domly selected patients of the 40,000
members of the Dutch Diabetes Association
were mailed a booklet of self-report ques-
tionnaires, including the PAID. To deter-
mine test–retest reliability, a random
sample of 250 patients from the total group
was invited for a second assessment 2
months later. PAID data from a U.S. sample
of 256 type 1 and type 2 diabetic patients
at the Joslin Diabetes Center (Boston, MA)
(15) were reanalyzed and compared with
the Dutch sample.
Measures
Self-reported demographic and clinical
characteristics of the subjects included age,
sex, marital status, monthly income, years
of education, age at onset of diabetes, treat-
ment regimen, number of complications,
most recent HbA1c level, comorbidity, fre-
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Diabetes-Related Emotional Distress in
Dutch and U.S. Diabetic Patients
Cross-cultural validity of the Problem Areas in Diabetes Scale
O R I G I N A L  A R T I C L E
OBJECTIVE — To examine the cross-cultural validity of the Problem Areas in Diabetes Scale
(PAID) in Dutch and U.S. diabetic patients.
RESEARCH DESIGN AND METHODS — A total of 1,472 Dutch people with diabetes
completed the PAID along with other self-report measures of affect. Statistics covered Cron-
bach’s , exploratory factor analysis (EFA), and confirmatory factor analysis (CFA), Pearson’s
product-moment correlation, and t tests. Psychometric properties of PAID were compared for
Dutch and U.S. diabetic patients.
RESULTS — Internal consistency of the Dutch PAID was high and stable across sex and type
of diabetes. Test–retest reliability was high. Principal component analyses confirmed 1 general
20-item factor, whereas EFA identified 4 new subdimensions: negative emotions, treatment
problems, food-related problems, and lack of social support. These dimensions were confirmed
with CFA and were replicated in the U.S. sample. The PAID and its subscales demonstrated
moderate to high associations in the expected direction with other measures of affect. Dutch
and U.S. subjects reported having the same problem areas, with U.S. patients reporting higher
emotional distress levels both in type 1 and type 2 diabetes.
CONCLUSIONS — The Dutch and U.S. 20-item PAID appeared to be psychometrically
equivalent, which allowed for cross-cultural comparisons.
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quency of self-monitoring of blood glucose
(SMBG), history of severe hypoglycemia,
hospital admission because of diabetic
ketoacidosis (DKA), and a history of psy-
chological/psychiatric treatment (yes/no).
In addition, patients were asked how bur-
densome they perceived their diabetes to
be on a 4-point Likert scale (from “very
burdensome” to “not burdensome”), their
satisfaction with life in general on a 5-point
Likert scale (from “very satisfied” to “very
unsatisfied”), and how they perceived their
health status on a 5-point Likert scale (from
“very good” to “very bad”). Subjects were
classified as having type 1 diabetes if they
were 40 years of age when their diabetes
was diagnosed and required insulin ther-
apy at the time of diagnosis. Those who did
not meet these criteria were classified as
having type 2 diabetes (19).
The PAID is a self-report questionnaire
that consists of 20 statements that Polonsky
et al. (14) identified as common negative
emotions related to living with diabetes
(e.g., “feeling alone with diabetes” and
“worrying about the future and the possi-
bility of serious complications”). Each item
can be rated on a 6-point Likert scale rang-
ing from 1 (“not a problem”) to 6 (“a seri-
ous problem”). Completing the PAID
generally takes 3–5 min. To facilitate inter-
pretation, PAID scores are transformed to a
0–100 scale, with higher scores indicating
greater emotional distress. Welch et al. (15)
found support for the convergent and dis-
criminative validity of the PAID in U.S.
patients. Factor analysis yielded 1 (20-
item) emotional adjustment factor that
proved to have high internal consistency
(Cronbach’s  = 0.95). Two authors (F.J.S.
and F.P.) translated the PAID into Dutch. A
back translation into English was made by
a professional native-speaking translator
and revealed no substantial differences.
The Worry subscale of the Dutch ver-
sion of the Hypoglycemia Fear Survey
(HFS) was used to measure fear of hypo-
glycemia (20,21). This scale contains 13
items with a 5-point Likert scale ranging
from 0 (“never”) to 4 (“always”). The Dutch
Worry scale was found to have good inter-
nal consistency (Cronbach’s  = 0.92)
The Dutch version of the 12-item
(Bradley) Well-Being Questionnaire
(WBQ-12) was used to measure general
emotional well-being (18,22). The WBQ-
12 consists of three 4-item subscales: Neg-
ative Well-Being (NWB), Energy (ENE),
and Positive Well-Being (PWB). Items are
rated on a 4-point Likert-scale ranging
from 3 (“all the time”) to 0 (“not at all”).
Subscale scores can be calculated for the
NWB, PWB, and ENE. The WBQ-12 was
found to have good internal consistency
( = 0.73–0.87) and good test–retest reli-
ability (0.66–0.80). Factorial and conver-
gent validity proved satisfactory.
Anxiety as a personality trait was
assessed with the Dutch version of the Trait
Anxiety subscale of the State Trait Anxiety
Inventory (STAI) (23,24). The STAI scale
consists of 20 items that refer to how
patients feel in general scored on a 4-point
Likert scale from 1 (“hardly ever”) to 4
(“almost always”). The Dutch STAI has
good internal consistency ( = 0.90) and
test–retest reliability (0.85).
Statistical analysis
SPSS 7.5 (SPSS, Chicago) (25) and EQS 5.1
for Windows (26) were used to carry out
statistical analyses.
A cross-validation design was used in
which the total sample was randomly
divided into groups 1 and 2. Then both
groups were split into subgroups 1a and 2a
(men with type 1 diabetes), 1b and 2b (men
with type 2 diabetes treated with insulin),
1c and 2c (men and women with type 2
diabetes treated with diet and/or oral hypo-
glycemic agents), 1d and 2d (women with
type 1 diabetes), and 1e and 2e (women
with type 2 diabetes treated with insulin).
Based on the findings of Welch et al. (15),
subdimensions of the PAID were expected
to be highly correlated, in which case factor
analysis with oblimin rotation is considered
the most appropriate technique (27). There-
fore, exploratory factor analysis (EFA) with
oblimin rotation was performed in group 1
as a whole. In group 2, we conducted con-
firmatory factor analysis (CFA) to test the
models that were found in group 1 using
the maximal likelihood estimation method.
The robust comparative fit index (CFI*)
was used to evaluate the fit of the models to
the data. A CFI* 0.90 is generally consid-
ered to be an indication of adequate fit (28).
In the EFAs, pairwise deletion was used
to handle missing data, whereas listwise
deletion was used in group 2 (CFA) as
demanded by the EQS program. A maxi-
mum of 2 missing values was estimated for
32 cases (4.4%) using the mean of their
remaining items; 21 cases (2.9%) with more
than 2 missing values on the PAID were
deleted from group 2. Cronbach’s  coeffi-
cients were calculated in groups 1 and 2.
Factorial validity of the PAID was reexam-
ined in the U.S. sample (15) using CFAs.
Mean PAID scores found in the Dutch
sample were compared with those found in
the U.S. sample using t tests. Similar to
Welch et al. (15), we expected type 1 dia-
betic patients to report higher levels of
emotional distress than type 2 diabetic
patients. No significant differences were
expected in mean PAID scores between
Dutch and U.S. patients.
To investigate convergent validity and
stability of the Dutch PAID in the total
group, Pearson’s product moment correla-
tion was used. A low positive association
(r = 0.10–0.20) was expected between the
PAID and self-reported HbA1c level. Mod-
erately high correlations (r = 0.30–0.50)
were expected between the PAID and the
other measures of effect (e.g., STAI, WBQ-
12, HFS). Women were expected to have
significantly higher PAID scores than men.
Discriminative validity was investigated
with t tests in the whole sample, and we
expected patients with psychological
comorbidity and/or a history of severe
hypoglycemia to score higher on the PAID
than the others.
To adjust for the high number of sta-
tistical tests (40–50), only P values 0.001
were considered to be significant.
RESULTS — The questionnaire was
returned by 1,472 people with diabetes
(49%). No data were available for the non-
respondents. Sex was almost equally dis-
tributed, with there being 722 women
(49%). Mean age was 51 ± 16 years. Most
subjects (75%) were married or cohabitat-
ing with a partner; 96% were Caucasian
and of Dutch origin. Mean duration of dia-
betes was 16 ± 12 years. A total of 739 sub-
jects were classified by us as having type 1
diabetes (51%), 502 had type 2 diabetes
treated with insulin (35%), and 199 had
type 2 diabetes treated with diet and/or
oral hypoglycemic agents (14%). Because
of missing data, the type of diabetes for 32
patients could not be determined. HbA1c
level was self-reported by 854 patients
(57%), of whom 63% had type 1 diabetes.
Most recent mean HbA1c level in the total
sample was 7.7 ± 1.5% with no significant
difference in type of diabetes. HbA1c level
was reported to have been determined on
average 2.5 ± 2.4 months before the ques-
tionnaire assessment. A total of 582 sub-
jects (41%) indicated that they suffered
from 1 or more diabetes-related complica-
tions, of whom 64% had retinopathy (type
not specified). The Dutch sample appeared
to be comparable with the U.S. sample
(15) in terms of age, sex, age at onset of
diabetes, diabetes duration, distribution of
type 1 and type 2 diabetes, and percentage
of type 2 patients treated with insulin
(70%). However, mean HbA1c level
appeared to be higher in the U.S. sample
(9.9 ± 1.8%).
The percentage of missing values was
low for all Dutch PAID items and ranged
from 1.9 (“feeling overwhelmed by your
diabetes regimen”) to 3.9% (“coping with
complications of the diabetes”).
Principal components analyses were
performed in group 1 (n = 736) with 2–4
components. In the 3 analyses, all 20 items
had high loadings on the first principal com-
ponent (ranging from 0.49 to 0.81). None of
the items had a loading on the second, third,
or fourth principal component that
exceeded their loading on the first principal
component with 0.10. Eigen values of the
4 components were 9.9, 1.2, 1.0, and 0.9,
which accounted for 49.5, 5.9, 5.1, and
4.4% of the variance, respectively. These
findings show a large general (20-item) fac-
tor to be present, as found earlier in the U.S.
sample. Next, forced EFAs with 2–4 factors
were conducted using oblimin rotation. In
the 2- and 3-factor solutions, a clear 13-item
“diabetes-related emotional problems” factor
was found, but the second and  third factor
were less homogeneous and not easy to
interpret. The 4-factor solution could more
clearly be interpreted as negative emotions
(12 items), treatment problems (3 items),
food-related problems (3 items), and lack of
social support (2 items). Two items showed
double loadings: “feeling alone with your
diabetes” (0.55 for social support and 0.48
for negative emotions) and “feeling unsatis-
fied with your diabetes physician” (0.68 for
treatment problems and 0.35 for lack of
social support). By using CFAs in groups
2a–e (n = 736), the 1-factor model was just
rejected with a robust CFI* of 0.89, whereas
the 4-factor model was accepted with a
CFI* of 0.94. In accordance with U.S. find-
ings, Cronbach’s  as a measure of internal
consistency proved to be high for the PAID
as a whole in groups 1a–e and 2a–e
(0.93–0.95) and thus appeared to be stable
across sex, type of diabetes, and treatment
regimen. Cronbach’s  for the 4 dimensions
for type 1 and type 2 diabetes were in the
range of 0.93 (emotions), 0.74–0.76 (treat-
ment), 0.70–0.74 (food), and 0.69–0.72
(social support).
The factor structure of the PAID was
reanalyzed in the U.S. sample using CFA.
Similar to the findings of Welch et al.
(15), the 1-factor model was accepted
with a robust CFI* of 0.93. However, the
4-factor model proved to be statistically
superior with a CFI* of 0.95, which con-
firms the Dutch model. Cronbach’s  for
the 4 PAID subdimensions in the U.S.
sample were in the same range as the
Dutch and ranged from 0.72 (social sup-
port) to 0.95 (emotions).
The Dutch PAID was completed for a
second time by a sample of 202 subjects
(response rate 81%) 66 ± 14 days after the
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Table 1—PAID mean scores on items and subdimensions for the Dutch and U.S. samples with type 1 and type 2 diabetes
Type 1 diabetes Type 2 diabetes
Subdimension The Netherlands U.S. The Netherlands U.S.
n 739 135 701 121
Diabetes-related emotional problems 16.9 ± 12.8 22.4 ± 15.2* 15.1 ± 13.5 17.9 ± 15.6
Feeling scared when you think about living with diabetes 1.0 ± 1.2 1.9 ± 1.8* 0.9 ± 1.4 1.8 ± 1.9*
Feeling depressed when you think about living with diabetes 1.2 ± 1.4 1.8 ± 1.7* 1.1 ± 1.4 1.4 ± 1.7
Not knowing if the mood or feelings you are experiencing are related to your 1.7 ± 1.5 1.9 ± 1.7 1.6 ± 1.6 1.8 ± 1.7
blood glucose
Feeling overwhelmed by your diabetes regimen 1.5 ± 1.5 1.6 ± 1.7 1.4 ± 1.5 1.3 ± 1.6
Worrying about low blood sugar reactions 1.6 ± 1.5 2.1 ± 1.7* 1.3 ± 1.5 1.2 ± 1.5
Feeling angry when you think about living with diabetes 1.1 ± 1.4 1.6 ± 1.7 1.0 ± 1.4 1.2 ± 1.6
Worrying about the future and the possibility of serious complications 2.3 ± 1.5 2.8 ± 1.7* 2.0 ± 1.6 2.5 ± 1.9
Feeling guilty or anxious when you get off track with your diabetes management 1.8 ± 1.5 2.5 ± 1.6* 1.6 ± 1.6 2.0 ± 1.7
Not accepting diabetes 0.9 ± 1.4 1.0 ± 1.4 0.8 ± 1.4 1.0 ± 1.4
Feeling that diabetes is taking up too much mental and physical energy 1.2 ± 1.4 1.7 ± 1.7* 1.1 ± 1.5 1.1 ± 1.4
Coping with complications of diabetes 1.5 ± 1.5 1.7 ± 1.6 1.5 ± 1.6 1.4 ± 1.6
Feeling constantly burned out by the constant effort to manage diabetes 1.2 ± 1.4 1.8 ± 1.7* 1.0 ± 1.4 1.3 ± 1.6
Treatment-related problems 2.8 ± 3.0 3.9 ± 3.6* 2.3 ± 3.0 3.2 ± 3.3
Not having clear and concrete treatment goals for your diabetes care 1.1 ± 1.3 1.3 ± 1.5 0.9 ± 1.2 1.2 ± 1.4
Feeling discouraged with your diabetes regimen 1.0 ± 1.2 1.8 ± 1.7* 0.8 ± 1.1 1.4 ± 1.7*
Feeling unsatisfied with your diabetes physician 0.8 ± 1.2 0.8 ± 1.3 0.7 ± 1.3 0.6 ± 1.2
Food-related problems 3.6 ± 3.3 4.6 ± 3.6* 3.7 ± 3.7 4.8 ± 3.9
Uncomfortable interactions around diabetes with family/friends (e.g., other 1.3 ± 1.5 1.2 ± 1.4 1.1 ± 1.6 1.3 ± 1.4
people telling you what to eat)
Feelings of deprivation regarding food and meals 1.2 ± 1.4 1.6 ± 1.5* 1.3 ± 1.5 1.7 ± 1.6
Feeling constantly concerned about food 1.1 ± 1.3 1.9 ± 1.6* 1.3 ± 1.5 1.8 ± 1.6*
Social support–related problems 1.4 ± 2.1 2.6 ± 2.7* 1.6 ± 2.4 1.8 ± 2.4
Feeling alone with diabetes 0.9 ± 1.3 1.6 ± 1.7* 1.0 ± 1.5 1.1 ± 1.5
Feeling that friends/family are not supportive of diabetes management efforts 0.5 ± 1.0 0.9 ± 1.3* 0.6 ± 1.2 0.7 ± 1.2
PAID 20-item scale 24.6 ± 18.7 33.4 ± 22.2* 22.5 ± 19.8 27.8 ± 23.2
*P  0.001. Items can range from 0 to 5.
first assessment. Pearson’s correlation
between these 2 assessments was 0.83 for
the total PAID and 0.80 (emotions), 0.64
(treatment), 0.74 (food), and 0.76 (social
support) for the subdimensions, which
suggests good stability.
Mean scores for the 20 PAID items, the
total PAID, and subdimensions are shown
in Table 1 by disease type for the Dutch
and U.S. samples. U.S. type 1 diabetic
patients reported significantly higher levels
of emotional distress than the Dutch on all
4 subdimensions. In type 2 diabetic
patients, the differences were less pro-
nounced, but a trend was observed. Both
in the Dutch and U.S. samples, “worrying
about the future and the possibility of seri-
ous complications” had the highest mean
score in type 1 and type 2 diabetic patients
followed by “feelings of guilt or anxiety
when you get off track with your diabetes
management” and “not knowing if the
mood or feelings you are experiencing are
related to your blood glucose.” All 3 items
are included in the negative emotions sub-
dimension of the PAID.
Convergent validity was examined by
calculating product-moment correlations
between the PAID and other measures of
affect (P  0.001). The associations found
were all according to expectations and are
summarized in Table 2. Perceived burden of
diabetes correlated strongly (0.60) with total
PAID, whereas a negative association (r =
0.46) was found when rating of overall sat-
isfaction with life. Perceived health status
correlated 0.35 with the PAID total. Age
and income showed weak negative associa-
tions with the PAID total (0.12 and 0.14,
respectively), whereas duration of diabetes
and years of education did not correlate
significantly with the PAID. As expected, a
weak positive correlation was found between
PAID total and self-reported HbA1c level and
frequency of SMBG. Women showed higher
total PAID scores than men (26.6 ± 19.9 vs.
20.9 ± 18.1, respectively; P  0.001).
Discriminative validity was supported
by the finding that subjects with a history
of psychological/psychiatric treatment (n =
175) had significantly higher scores on the
total PAID than subjects without such his-
tory (34.6 ± 22.0 vs. 22.0 ± 18.2, respec-
tively). Patients reporting 1 or more severe
hypoglycemic events during the past 6
months (defined as requiring assistance of
another person, n = 236) had significantly
higher total PAID scores compared with
subjects without hypoglycemic episodes
(28.6 ± 20.4 vs. 22.4 ± 18.7, respectively).
Also, subjects reporting 1 or more DKA
episodes during the past 12 months (n =
27) had higher scores than subjects without
DKA episodes (31.8 ± 21.9 vs. 23.5 ± 19.2,
respectively) (P  0.001).
CONCLUSIONS — In this study, the
reliability and validity of the PAID were
examined across Dutch and U.S. patients
with diabetes. The Dutch PAID had good
internal consistency and factorial validity,
and we found support for its convergent
and discriminative validity. The Dutch PAID
was relatively stable during a period of 2
months, but further research is needed to
examine long-term stability and respon-
siveness to change. Similar to the findings of
Welch et al. (15), we found that the factor
structure can be represented by a 1-factor
model, which supports the current use of
the total score of the PAID. However, a 4-
factor solution appeared to best fit the
Dutch and U.S. data. Further research is
needed to determine whether this 4-factor
model can be replicated in other cultural
adaptations of the PAID, including in Japan-
ese subjects (17). The utility of this model in
clinical practice has yet to be proved.
When comparing PAID scores across
U.S. and Dutch type 1 and type 2 diabetic
patients, similar problem areas were identi-
fied as the most stressful, but the U.S.
patients reported higher levels of distress.
This may reflect cross-cultural differences in
experienced distress between Dutch and
U.S. patients similar to those found in anx-
iety disorders and depression (29,30). Alter-
natively, differences in mean scores may be
biased by patient selection, although no
substantial differences in demographic and
clinical characteristics between both sam-
ples were observed. The Dutch sample con-
sisted of members of the Dutch Diabetes
Association who were willing to fill out
questionnaires, whereas Welch et al. (15)
studied consecutive outpatients at an U.S.
specialist diabetes clinic. Unfortunately, a
more detailed comparison of clinical char-
acteristics between both samples was not
possible in this study because the data from
the Dutch sample were based on self-report.
The apparent difference in mean HbA1c
level between the Dutch and U.S. patients
may reflect a true difference in glycemic
control but may also have been caused by
social desirability and/or differences in lab-
oratory procedures. Future studies compar-
ing PAID scores across cultures should
include objective measures of glycemic con-
trol and health care received to control for
differences in quality of diabetes care. Psy-
chometric research on the PAID in different
care settings and various ethnic and socioeco-
nomic patient groups across cultures is war-
ranted. In summary, the Dutch PAID is a
promising brief assessment tool that may
stimulate international comparison of the
experience of living with diabetes and
effects of interventions.
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